Form D · Other Health Care
Sterilucent, Inc.
Minneapolis, MN · CIK 0001514013
Offering snapshot reported Apr 14, 2015 · SEC filing
- Reported sold
- $565K Offering amount: $990K
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 25, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 14, 2015 | Initial | $564,996 | No comparison | 3 | SEC filing |
| Apr 14, 2015 | Initial | $3,395,000 | No comparison | 11 | SEC filing |
| May 27, 2011 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| May 27, 2011 | Amendment | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-237888
Source: Form D, filed Apr 14, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David C. Bell | Director, Executive |
| Shawn L. Featherston | Director |
| Gary Moore | Executive |
| Alan Roth | Executive |
| Daniel M. Stenoien | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1400 Marshall Street Ne
Minneapolis, MN, 55413
Minneapolis, MN, 55413